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aSaudi ArabiaIntroduction: Coronary artery disease is the leading cause of death worldwide. Although there are a number of
algorithms in use for determining the risk of coronary artery disease and thus predicting future cardiovascular events,
the data available regarding their validity among the Saudi population are insufficient.
Objective: Westudied the validity of three clinical score systems inpredicting a high risk populationdefined as hav-
ing excessive coronary calcification: the American College of Cardiology/American Heart Association (ACC/AHA)
Pooled Cohort Risk Equation, the Framingham Risk Score, and the European Systematic Coronary Risk Evaluation.
Methods: We analyzed data from 462 patients aged P40 years. High-risk features were if the Coronary Calcium
Scorewas either >400 or in theP75th percentile usingMulti-Ethnic Study ofAtherosclerosis (MESA) score. The scores
for the three algorithms were then calculated using the participants’ clinical data.
Results: A total of 87 (18.8%) patients were positive for coronary calcification. Among them, 60 (13%) were classified
as being at high risk according to the MESA score. Analyzing these patients by the ACC/AHA Pooled Cohort Risk
Equation resulted in nine (15%) as being at low risk, 12 (20%) at intermediate risk, and 39 (65%) at high risk. The Fram-
inghamRisk classification resulted in 14 (23%)being at low risk, 13 (22%) at intermediate risk, and 33 (55%) at high risk.
The European Systematic Coronary Risk Evaluation risk classification showed 24 (40%) at low risk, 12 (20%) at inter-
mediate risk, and 24 (40%) at high risk, with p < 0.0001.
Conclusion: The ACC/AHA Pooled Cohort Risk Equation has superior risk calibration compared to the other two
risk-score algorithms in a Saudi population.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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scoreIntroduction
Coronary artery disease (CAD) is the mostcommon cause of death worldwide, repre-
senting a disease burden in both developing andunderdeveloped countries [1]. In the USA, mortal-
ity due to cardiovascular diseases accounted for
34.3% of all deaths in 2006. Furthermore, it was
reported that in 2010 an American experienced a
coronary event approximately every 25 seconds
while someone died from a coronary eventeCCBY-
(2016),
Abbreviations
ACC/AHA the American College of Cardiology/American
Heart Association
CAD Coronary artery disease
FRS Framingham Risk Score
CCS Coronary Calcium Score
MDCT multidetector computed tomography
MESA Multi-Ethnic Study of Atherosclerosis
SCORE the EuropeanSystematicCoronaryRiskEvaluation
ASCVD atherosclerotic cardiovascular disease
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indirect costs of CAD and stroke in the USA are
estimated to be $503.2 billion—higher than for
any other diagnostic group [2].
The best strategy for the management of CAD is
early detection and control of risk factors such as
diabetes mellitus, hypertension, dyslipidemia,
and cigarette smoking. In addition, risk stratifica-
tion for future cardiovascular events has an
important role in identifying patients at higher
risk.
Multiple risk score algorithms are available that
can predict the 10-year risk of atherosclerotic car-
diovascular diseases (ASCVD), the most com-
monly utilized being the Framingham Risk Score
(FRS), the European Systematic Coronary Risk
Evaluation (SCORE), and the American College
of Cardiology/American Heart Association
(ACC/AHA) Pooled Cohort Risk Equation [3,4].
In Saudi Arabia, patients with acute coronary
syndrome are almost a decade younger than those
in developed countries [5], warranting early detec-
tion of those at high risk. However, to date no data
testing the validity of risk stratification systems in
the Saudi population have been published. The
aim of this study was to analyze and compare
the accuracy of these systems in identifying
patients at higher risk for ASCVD.Figure 1. Methods of patient enrollment to the analysis. ACC/
AHA = American College of Cardiology/American Heart Association;
MDCT = Multidetector computed tomography; FRS = Framingham
Risk Score; MESA = Multi-Ethnic Study of Atherosclerosis;
SCORE = European Systematic Coronary Risk Evaluation.Methods
Study settings and participants
A cross-sectional analysis of 918 patients under-
went multidetector row computed tomography
(MDCT) scan between January 2010 and Decem-
ber 2014 to evaluate the validity of three risk strat-
ification systems in identifying patients at higher
risk defined by the Coronary Calcium Score
(CCS). Four hundred and sixty two patients older
than 40 years were enrolled for the final analysis,
while 456 patients were excluded (Fig. 1). The
study protocol was approved by the Institutional
and Regional Ethical Committee.
Patients’ characteristics
Variables such as sex, race, and ethnicity were
obtained by self-reporting. Risk factors for CAD
such as hypertension, diabetes mellitus, dyslipi-
demia, family history of premature CAD, and
smoking history were obtained. Total cholesterol,
low-density lipoprotein, and high-density lipopro-
tein were recorded before MDCT scan. In addi-
tion, systolic blood pressure, weight, height,
waist and hip circumference, and waist–hip ratio
were measured, and body mass index calculated.Please cite this article in press as: Abazid R. et al., Analysis of three risk st
http://dx.doi.org/10.1016/j.jsha.2016.06.002CT protocol
Participants underwent a noncontrast, low-
radiation calcium-scoring scan (dual-source,
Definition Flash; Siemens Healthcare, Forchheim,
Germany) with a gantry rotation time of
0.28 seconds. Imaging parameters included
2  128  3-mm slice collimation with 3-mm slices
of a field of view extending from the tracheal
bifurcation to the diaphragm. The scan was
taken with breath-hold and a prospectively
electrocardiography-triggered protocol with
image acquisition initiated at 70% of the cardiac
cycle. The imaging parameters were 120 kVp,
0.33-seconds temporal resolution, and 3-mm slice
thickness.CT image analysis
Images were reconstructed and analyzed using
an Advantage Windows AW4 (GE Healthcare,
Waukesha, WI, USA) to measure the calcium
score using the Agatston method.ratification systems in a Saudi population, J Saudi Heart Assoc (2016),
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RISK STRATIFICATION IN SAUDI POPULATIONIdentification of high-risk groups
All patients with either a CCSP400 or a CCS in
the P75th percentile using the online sex-specific
Multi-Ethnic Study of Atherosclerosis (MESA)
score calculator [6] were identified as high risk.Calculation of clinical risk scores
Patients’ clinical data and lipid profiles were
used to calculate the three clinical risk scores,
namely sex-specific FRS, sex-specific SCORE,
and sex- and race-specific ACC/AHA Pooled
Cohort Risk Equation, using age, diabetes melli-
tus, total cholesterol level, high-density lipopro-
tein level, smoking status, systolic blood
pressure, and use of antihypertensive medication
[4,7,8].Table 1. Baseline characteristics.
Variables
Age (y), mean ±SD 52 ± 8
Male sex, n (%) 315 (68)
Body mass index (kg/m2),
mean ± SD
29.9 ± 4.7
Body weight (kg), mean ± SD 83.2 ± 13
Diabetes mellitus, n (%) 128 (27.5)
Hypertension, n (%) 207 (44.7)
Dyslipidemia, n (%) 24 (5)
Family history of coronary artery
disease, n (%)
33 (7)
Current smoking, n (%) 80 (17.4)
Cholesterol (mmol/L), mean ± SD 4.2 ± 1.3
Low-density lipoprotein
(mmol/L), mean ± SD
2.6 ± 1.1
High-density lipoprotein
(mmol/L), mean ± SD
1.2 ± 0.3
Coronary calcium score 31 ± 136
SD = standard deviation.
Table 2. Comparison between the high- and low-risk group.
Variables High-risk group
No. of patients 60 (13)
Age (y), mean ± SD 54 ± 10
No. of men, n (%) 45 (75)
Diabetes, n (%) 32 (53)
Hypertension, n (%) 42 (70)
Smoking, n (%) 8 (13)
Dyslipidemia, n (%) 5 (8)
Family history of
coronary artery
disease, n (%)
8 (13)
Coronary calcium
score, mean ± SD
230 ± 315
SD = standard deviation.
Please cite this article in press as: Abazid R. et al., Analysis of three risk st
http://dx.doi.org/10.1016/j.jsha.2016.06.002Statistical analysis
Quantitative variables were expressed as
mean ± standard deviation and categorical vari-
ables were expressed as frequencies or percent-
ages. For normally distributed continuous
variables a two-sample t test was performed, and
Chi-square exact tests were run for categorical
variables to compare the high- and low-risk
groups defined by MESA score. A value of
p < 0.05 was considered statistically significant
for all tests. All statistical analyses were per-
formed using SPSS for Windows (Version 19.0;
SPSS Inc., Chicago, IL, USA).Results
Baseline characteristics
Baseline characteristics of the 462 patients are
shown in Table 1. The mean age of the patients
was 52 ± 8 years, with 315 (68%) of them being
men. Coronary artery calcification was present in
87 (18.8%), of whom 69 (14.9%) were men and 18
(3.9%) were women.
MESA score and high-risk patients
Using the MESA score calculator, 60 (13%)
patients were in the P75th percentile and com-
prised the high-risk group. Chi-square exact test
analysis showed a significantly higher prevalence
of Diabetes mellitus and Hypertension in the
high-risk than in the lower-risk group (Table 2).
Ten-year calculated risk
The expected 10-year risk for each system was
stratified into three categories as low, intermedi-
ate, and high. Analysis of all patients using the
ACC/AHA Pooled Cohort Risk Equation resulted
in 264 (57%) classified as low risk, 60 (13%) asLow-risk group p
402 (87)
51 ± 8 0.09
270 (14) 0.3
96 (24) <0.0001
165 (41) 0.001
72 (18) 0.27
19 (4.7) 0.3
25 (6.2) 0.1
1 ± 6 <0.0001
ratification systems in a Saudi population, J Saudi Heart Assoc (2016),
Figure 2. Risk stratification of all participants. ACC/AHA = American College of Cardiology/American Heart Association; FRS = Framingham
Risk Score; SCORE = European Systematic Coronary Risk Evaluation.
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FRS, 198 (42%) were classified as low, 132 (29%) as
intermediate, and 132 (29%) as high risk. Using the
SCORE system, 300 (65%) were classified as low,
48 (10%) as intermediate, and 114 (25%) as high
risk (Fig. 2).
The three scoring systems overestimated the
predicted cardiovascular risk by 130% for the
ACC/AHA pooled cohort risk equation, 120% for
FRS, and 90% for SCORE.
Patients with a high MESA score
Analyzing these patients using the ACC/AHA
Pooled Cohort Risk Equation resulted in nine
(15%) as being at low risk, 12 (20%) at intermediate
risk, and 39 (65%) at high risk. The FRS riskFigure 3. Risk stratification of high risk group showed that American Co
Cohort Risk Equation to be more sensitive than Framingham Risk Score (FR
in identifying patients at high risk.
Please cite this article in press as: Abazid R. et al., Analysis of three risk st
http://dx.doi.org/10.1016/j.jsha.2016.06.002classification showed 14 (23%) at low risk, 13
(22%) at intermediate risk, and 33 (55%) at high
risk. The SCORE risk classification demonstrated
24 (40%) at low risk, 12 (20%) at intermediate risk,
and 24 (40%) at high risk (p < 0.0001; Fig. 3).Discussion
In the present study, we tested the utility of
three different risk stratification systems in pre-
dicting patients with a high 10-year ASCVD risk.
We found the ACC/AHA Pooled Cohort Risk
Equation to be more sensitive than FRS and
SCORE in identifying patients at high risk among
the Saudi population. In addition we found that
diabetes mellitus and hypertension were thellege of Cardiology/American Heart Association (ACC/AHA) Pooled
S) and the European Systematic Coronary Risk Evaluation (SCORE)
ratification systems in a Saudi population, J Saudi Heart Assoc (2016),
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defined by higher coronary calcification.
Cardiovascular diseases is a major health issue
in Saudi Arabia, with approximately 5.5% of the
population in the age group 30–70 years having
CAD [9]. Furthermore, the Saudi Project for
Assessment of Coronary Events registry has
reported a higher prevalence of CAD risk factors
among patients presenting with acute coronary
syndrome and a higher prevalence of diabetes
mellittus in comparison with individuals in devel-
oped countries [5].
Cardiovascular risk stratification is considered
an important strategy that aims to classify the gen-
eral population into either low-, intermediate-, or
high-risk groups, which may help in identifying
individuals susceptible to hard cardiovascular
events and in predicting persons who might
benefit from preventative measures, thus result-
ing in less cardiovascular mortality by decreasing
the prevalence of risk factors for CAD [10,11]
and increasing the implementation of various pri-
mary prevention methods, such as the use of
aspirin, lowering of blood pressure and low-
density lipoprotein cholesterol in the indicated
group, and reduction of body weight in cases of
adiposity [12,13].
At present there are multiple risk stratification
algorithms in use. For decades FRS was the most
widely used for the calculation of 10-year risk in
asymptomatic individuals. However, the FRS
underestimates the lifetime risk, especially in
younger individuals with multiple risks and in
women; moreover, it does not predict the inci-
dence of stroke [14,15]. This necessitated the intro-
duction of the ACC/AHA Pooled Cohort Risk
Equation to overcome these limitations. In this
system diabetes mellitus was included as a predic-
tor variable, and fatal and nonfatal stroke were
added to the ASCVD end points [16,17].
Many studies showed that coronary calcification
detected using noncontrast MDCT can accurately
predict the coronary plaque burden, with a high
correlation of >0.9 between CCS and coronary pla-
que area [18]. In addition, CCS can provide prog-
nostic information regarding the risk of hard
cardiovascular events. With a CCS P400 there is
2.5-fold increase in cardiovascular diseases risk
when compared with a CCS <10. CCS is consid-
ered an independent predictor, and superior to
the traditional risk factor of CAD in the assess-
ment of subclinical CAD and future ASCVD
events [6,19,20].
In the present study, we found that all the three
risk stratification systems tend to overestimate thePlease cite this article in press as: Abazid R. et al., Analysis of three risk st
http://dx.doi.org/10.1016/j.jsha.2016.06.002predicted cardiovascular risk by 90% to 130%. A
recent study by DeFilippis et al. [21] investigated
five different risk scores and reported findings
consistent with the present study. These investi-
gators found that the ACC/AHA Pooled Cohort
Risk Equation system and the FRS tended to over-
estimate the risk by 86% and 53%, respectively,
while the SCORE was not tested. Similar findings
were reported by Muntner et al. [22], who found
that the observed and predicted 5-year cardiovas-
cular diseases events in their cohort in the REa-
sons for Geographic and Racial Differences in
Stroke and ACC/AHA Pooled Cohort Risk Equa-
tion were similar, but found an apparent overesti-
mation of risk mainly in the group with a 10-year
ASCVD risk P10%.
Risk overestimation may lead clinicians to start
patients on medications for primary prevention
that is not indicated, which may expose them to
otherwise avoidable adverse effects. However, it
may negatively affect the cost-effectiveness of
the primary prevention program. For these rea-
sons, further studies with long-term follow-up of
ASCVD events are needed for a better assessment
of risk stratification algorithms.
The present study indicated that the ACC/AHA
Pooled Cohort Risk Equation is more sensitive
than other risk scores in the Saudi population, so
its use in asymptomatic individuals should pro-
vide valuable information regarding future car-
diac risk, and may indicate persons who might
benefit from measures taken to prevent ASCVD.
Our study has certain limitations: it is a single-
center study and is a cross-sectional analysis that
depends mainly on the CCS as the gold standard
approach to identify the high-risk group, with no
follow-up of patients for any ASCVD events. In
this study the sample size was relatively small
and the high-risk group consisted of a small per-
centage of the total patient cohort.Conclusion
Among the Saudi population, the ACC/AHA
Pooled Cohort Risk Equation has a higher sensi-
tivity than FRS and SCORE in predicting patient’s
future risk driven by the MESA score. Further evi-
dence is needed to verify the validity of the test in
formulating preventive measures for ASCVD.Acknowledgement
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